Provider
QP33-20 Updates to Telemedicine/Telehealth and Telephone Call Reimbursement Policies
Program effective Date: Mar 25, 2020
Documents & Forms Results
Displaying 2861 - 2870 of 3600 results
Provider
QP28-20 Updated Service Type Options for Surgery on Availity Portal
Program effective Date: Mar 25, 2020
Provider
QP29-20 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Peanut Allergy
Program effective Date: Mar 25, 2020
Provider
QP30-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Program effective Date: Mar 25, 2020
Provider
QP31-20 Commercial Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Oxbryta™
Program effective Date: Mar 25, 2020
Provider
QP27-20 Coronavirus (COVID-19) Information for Providers
Program effective Date: Mar 11, 2020
Provider
QP25-20 Pharmacy Benefit Exclusion for Injectafer®, Feraheme®, Venofer®, INFeD®, Ferrlecit®, and generic Ferrlecit®
Program effective Date: Mar 11, 2020
Provider
QP26-20 CMS Decision Memo on Acupuncture for Chronic Low Back Pain
Program effective Date: Mar 11, 2020
Provider
QP24-20 Pharmacy Benefit Update – Addition of Drugs to Existing Prior Authorization (PA) with Quantity Limit (QL) Programs
Program effective Date: Mar 11, 2020
Provider
QP8R1-20 Update: Medical Drug Update for Golodirsen (Vyondys 53)
Program effective Date: Mar 11, 2020